GLOBAL MARKETS FOR SPECIALTY SURGICAL WOUND CARE PRODUCTS IN 2013: SURGICAL SEALANTS, GLUES, ABSORBABLE HEMOSTATS, AND ADHESION PREVENTION PRODUCTS

111 Pages | 52 Exhibits | 2013 Analysis

OVERVIEW:
The global market for specialty surgical wound care products-which include sealants, glues, absorbable hemostats, and adhesion prevention products-was valued at $3.1 billion in 2012. Growth is being largely driven by the markets of Asia-Pacific and the Rest-of-the-World, where greater product availability, new indications, and underlying market dynamics-such as rising surgical procedure volumes-are helping to offset sluggishness in the U.S. market. While global revenues are expected to reach $4.2 billion in 2018, key trends, such as efforts to limit expensive hospital admissions, shift procedures to outpatient settings, and reduce rates of readmissions, will have decisive effects on the market for these technologies.

Critical Issues Covered in this Report:
     •Analysis of the clinical status of key technologies as well as potential new indications and product       introductions;
     •The competitive landscape for these products in the U.S. and international markets; and
     •Market quantities, including procedure volumes, units, revenues per procedure, and detailed segmentation       among product categories.


TABLE OF CONTENTS:



1. EXECUTIVE SUMMARY

1.1 The U.S. Market for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products 
1.2 The European Market for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products 
1.3 The Market for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products in AP & ROW Countries 
1.4 Global Supplier Shares 

Exhibit 1-1: The Global Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products by Product Type 
Exhibit 1-2: The Global Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products by Region 
Exhibit 1-3: The U.S. Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products by Product Type 
Exhibit 1-4: The European Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products by Product Type 
Exhibit 1-5: The AP & ROW Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products by Product Type 
Exhibit 1-6: Global Supplier Shares in 2011 and 2012 

2. OVERVIEW

2.1 The Wound Healing Process 
	2.1.1 The Inflammatory Phase 
	2.1.2 Proliferative Phase 
	2.1.3 Remodeling Phase 
2.2 Types of Wound Healing 
2.3 Products 
	2.3.1 Sutures 
	2.3.2 Staples 
	2.3.3 Tapes 
	2.3.4 Surgical Adhesives 

Exhibit 2-1: The Three Stages of the Wound Healing Process 
Exhibit 2-2: Types of Wound Healing 
Exhibit 2-3: Types of Products Used in Wound Closure 

3. SURGICAL SEALANTS, GLUES, ABSORBABLE HEMOSTATS, & ADHESION PREVENTION PRODUCTS

3.1 Indications 
3.2 Product Types 
	3.2.1 Sealants 
	3.2.2 Glues 
	3.2.3 Absorbable Hemostats 
	3.2.4 Adhesion Prevention Products 
3.3 Companies and Products 

Exhibit 3-1: Surgical Sealants, Glues, Absorbable Hemostats, and Adhesion Prevention Products 
Exhibit 3-2: Leading Indications for Surgical Wound Closure Products 
Exhibit 3-3: Surgical Sealants, Glues, Absorbable Hemostats, and Adhesion Prevention Products in 2013 

4. PROCEDURES & MARKET FORECASTS: SURGICAL SEALANTS, GLUES, ABSORBABLE HEMOSTATS, & ADHESION PREVENTION PRODUCTS

4.1 The United States: Procedures & Market Forecasts 
	4.1.1 Surgical Sealants in the U.S.: Procedures & Market Forecasts 
	4.1.2 Surgical Glues in the U.S.: Procedures & Market Forecasts 
	4.1.3 Absorbable Hemostats in the U.S.: Procedures & Market Forecasts 
	4.1.4 Adhesion Prevention Products in the U.S.: Procedures & Market Forecasts 
	4.1.5 Supplier Shares 
4.2 Europe: Procedures & Market Forecasts 
	4.2.1 Surgical Sealants in Europe: Procedures & Market Forecasts 
	4.2.2 Surgical Glues in Europe: Procedures & Market Forecasts 
	4.2.3 Absorbable Hemostats in Europe: Procedures & Market Forecasts 
	4.2.4 Adhesion Prevention Products in Europe: Procedures & Market Forecasts 
4.3 Asia-Pacific & the Rest-of-the-World: Procedures & Market Forecasts 
	4.3.1 Surgical Sealants in AP & ROW Countries: Procedures & Market Forecasts 
	4.3.2 Surgical Glues in AP & ROW Countries: Procedures & Market Forecasts 
	4.3.3 Absorbable Hemostats in AP & ROW Countries: Procedures & Market Forecasts 
	4.3.4 Adhesion Prevention Products in AP & ROW Countries: Procedures & Market Forecasts 
4.4 OUS Supplier Shares 

Exhibit 4-1: The Global Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products by Product Type 
Exhibit 4-2: The Global Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products by Region 
Exhibit 4-3: The U.S. Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products by Product Type 
Exhibit 4-4: Targeted Surgical Caseloads in the U.S. from 2011-2018 
Exhibit 4-5: Factors Influencing the U.S. Market for Surgical Sealants 
Exhibit 4-6: The U.S. Market Forecast for Surgical Sealants from 2011-2018 
Exhibit 4-7: The U.S. Market Forecast for External and Internal Tissue Sealants from 2011-2018 
Exhibit 4-8: Factors Influencing the U.S. Market for Surgical Glues 
Exhibit 4-9: The U.S. Market Forecast for Surgical Glues from 2011-2018 
Exhibit 4-10: The U.S. Market Forecast for Surgical Glues, Approved & Off-Label Uses, from 2011-2018 
Exhibit 4-11: Factors Influencing the U.S. Market for Absorbable Hemostats 
Exhibit 4-12: The U.S. Market Forecast for Absorbable Hemostats from 2011-2018   
Exhibit 4-13: Factors Influencing the U.S. Market for Adhesion Prevention Products   
Exhibit 4-14: The U.S. Market Forecast for Adhesion Prevention Products from 2011-2018 
Exhibit 4-15: U.S. Supplier Shares in 2011 and 2012 
Exhibit 4-16: The European Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products by Product Type 
Exhibit 4-17: Targeted Surgical Caseloads in Europe from 2011-2018 
Exhibit 4-18: Factors Influencing the European Market for Surgical Sealants 
Exhibit 4-19: The European Market Forecast for Surgical Sealants from 2011-2018   
Exhibit 4-20: The European Market Forecast for External and Internal Tissue Sealants from 2011-2018 
Exhibit 4-21: Factors Influencing the European Market for Surgical Glues 
Exhibit 4-22: The European Market Forecast for Surgical Glues from 2011-2018 
Exhibit 4-23: The European Market Forecast for Surgical Glues from 2011-2018: Open Repairs of the Large Vessels & Other Indications 
Exhibit 4-24: Factors Influencing the European Market for Absorbable Hemostats   
Exhibit 4-25: The European Market Forecast for Absorbable Hemostats from 2011-2018 
Exhibit 4-26: Factors Influencing the European Market for Adhesion Prevention Products 
Exhibit 4-27: The European Market Forecast for Adhesion Prevention Products from 2011-2018 
Exhibit 4-28: The AP & ROW Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products by Product Type 
Exhibit 4-29: Targeted Surgical Caseloads in AP & ROW Countries from 2011-2018   
Exhibit 4-30: Factors Influencing the Market for Surgical Sealants in AP & ROW Countries 
Exhibit 4-31: The AP & ROW Market Forecast for Surgical Sealants from 2011-2018   
Exhibit 4-32: The AP & ROW Market Forecast for External and Internal Tissue Sealants from 2011-2018 
Exhibit 4-33: Factors Influencing the Market for Surgical Glues in AP & ROW Countries 
Exhibit 4-34: The AP & ROW Market Forecast for Surgical Glues from 2011-2018 
Exhibit 4-35: The AP & ROW Market Forecast for Surgical Glues from 2011-2018: Open Repairs of the Large Vessels & Other Indications 
Exhibit 4-36: Factors Influencing the Market for Absorbable Hemostats in AP & ROW Countries 
Exhibit 4-37: The AP & ROW Market Forecast for Absorbable Hemostats from 2011-2018 
Exhibit 4-38: Factors Influencing the Market for Adhesion Prevention Products in AP & ROW Countries 
Exhibit 4-39: The AP & ROW Market Forecast for Adhesion Prevention Products from 2011-2018 
Exhibit 4-40: OUS Supplier Shares in 2011 and 2012 

5. COMPANY PROFILES

5.1 Baxter International 
5.2 Covidien 
5.3 CryoLife 
5.4 CSL Behring 
5.5 Davol (C.R. Bard) 
5.6 Ethicon (Johnson & Johnson) 
5.7 Genzyme (Sanofi-Aventis) 
5.8 Pfizer 
5.9 Takeda Pharmaceuticals International 
5.10 Zymogenetics (Bristol-Myers Squibb) 


COMPANIES COVERED:

  1. Baxter International
  2. Covidien
  3. CryoLife
  4. CSL Behring
  5. Davol (C.R. Bard)
  6. Ethicon (Johnson & Johnson)
  7. Genzyme (Sanofi-Aventis)
  8. HemCon Medical Technologies
  9. Hyperbranch Medical Technology
  10. King Pharmaceuticals (Pfizer)
  11. MAST Biosurgery
  12. Medafor
  13. Neomend
  14. Orthovita (Stryker)
  15. Pfizer
  16. Takeda Pharmaceuticals International
  17. Tenaxis Medical
  18. ThermoGenesis
  19. Tissuemed
  20. Vivostat A/S
  21. Zymogenetics (Bristol-Myers Squibb)
Contact Us

Need help finding medtech research? Let us help you!